Pharmacokinetics, safety, and immunogenicity of HLX03, an adalimumab biosimilar, compared with reference biologic in healthy Chinese male volunteers: Results of a randomized, double‐blind, parallel‐controlled, phase 1 study

Abstract The primary objective of this randomized, double‐blind, parallel‐controlled study (from December 2016 to October 2018) was to evaluate pharmacokinetic (PK) equivalence of adalimumab biosimilar HLX03 and reference adalimumab in healthy volunteers, and to assess safety, and immunogenicity of...

Full description

Saved in:
Bibliographic Details
Main Authors: Hong Zhang (Author), Min Wu (Author), Jixuan Sun (Author), Xiaoxue Zhu (Author), Cuiyun Li (Author), Yanhua Ding (Author), Xiaodi Zhang (Author), Katherine Chai (Author), Xiaojiao Li (Author)
Format: Book
Published: Wiley, 2021-04-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available